Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$2.1 - $3.93 $175,728 - $328,862
-83,680 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$2.35 - $3.83 $54,155 - $88,262
23,045 Added 38.01%
83,680 $291,000
Q4 2018

Feb 14, 2019

BUY
$2.13 - $4.8 $101,675 - $229,128
47,735 Added 370.04%
60,635 $140,000
Q3 2018

Nov 14, 2018

BUY
$2.6 - $4.6 $33,540 - $59,339
12,900 New
12,900 $50,000

About ACELRX PHARMACEUTICALS INC


  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.